Sign In
or Login with
Check this out! We've a new feature you should know about. Click here!
Just a heads Up! 3 new Users are now following you!
Oops... portfolio named 'My Portfolio' already exists. Try a different name!
Woah... Successfully created portfolio 'Smart Investments' !

MESSAGES

Platinum Member
1390 Followers

the pharma major has launched the drug-free, non-invasive migraine management wearable device nerivio in germany through its step-down subsidiary betapharm. nerivio is approved by the united states food and drug administration (usfda) and is ce-mark-certified in europe. last year, the company entered into an exclusive agreement with theranica for the marketing and distribution of nerivio in multiple markets.

36 days 14 hrs 45 min 27 sec   |  Track
  I agree to the M3 code of conduct
No Replies
Explore Topics

MARKET VIEW

OUTLOOK

SECTORS

STRATEGY

VIEW

PERSONAL FINANCE

INSURANCE

INVEST

MUTUAL FUND

Login or Sign up now!
DID YOU KNOW?